ID   KGP2_HUMAN              Reviewed;         762 AA.
AC   Q13237; B4DMX3; E7EPE6; O00125; O60916;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=cGMP-dependent protein kinase 2;
DE            Short=cGK 2;
DE            Short=cGK2;
DE            EC=2.7.11.12;
DE   AltName: Full=cGMP-dependent protein kinase II;
DE            Short=cGKII;
GN   Name=PRKG2; Synonyms=PRKGR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8607838; DOI=10.1006/bbrc.1996.0477;
RA   Orstavik S., Solberg R., Taskn K., Nordahl M., Altherr M.R.,
RA   Hansson V., Jahnsen T., Sandberg M.;
RT   "Molecular cloning, cDNA structure, and chromosomal localization of
RT   the human type II cGMP-dependent protein kinase.";
RL   Biochem. Biophys. Res. Commun. 220:759-765(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7498513; DOI=10.1016/0014-5793(95)01223-2;
RA   Fujii M., Ogata T., Takahashi E., Yamada K., Nakabayashi K., Oishi M.,
RA   Ayusawa D.;
RT   "Expression of the human cGMP-dependent protein kinase II gene is lost
RT   upon introduction of SV40 T antigen or immortalization in human
RT   cells.";
RL   FEBS Lett. 375:263-267(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-734.
RX   PubMed=9535793; DOI=10.1006/bbrc.1998.8399;
RA   Witczak O., Orstavik S., Natarajan V., Frengen E., Jahnsen T.,
RA   Sandberg M.;
RT   "Characterization of the gene encoding the human type II cGMP-
RT   dependent protein kinase.";
RL   Biochem. Biophys. Res. Commun. 245:113-119(1998).
RN   [6]
RP   MYRISTOYLATION AT GLY-2, AND SUBCELLULAR LOCATION.
RX   PubMed=8636133; DOI=10.1074/jbc.271.12.7025;
RA   Vaandrager A.B., Ehlert E.M., Jarchau T., Lohmann S.M., de Jonge H.R.;
RT   "N-terminal myristoylation is required for membrane localization of
RT   cGMP-dependent protein kinase type II.";
RL   J. Biol. Chem. 271:7025-7029(1996).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-106 AND ARG-716.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 137-418 IN COMPLEX WITH CAMP
RP   AND CGMP, ENZYME REGULATION, AND MUTAGENESIS OF ASP-412 AND ARG-415.
RX   PubMed=26769964; DOI=10.1074/jbc.M115.691303;
RA   Campbell J.C., Kim J.J., Li K.Y., Huang G.Y., Reger A.S., Matsuda S.,
RA   Sankaran B., Link T.M., Yuasa K., Ladbury J.E., Casteel D.E., Kim C.;
RT   "Structural basis of cyclic nucleotide selectivity in cGMP-dependent
RT   protein kinase II.";
RL   J. Biol. Chem. 291:5623-5633(2016).
CC   -!- FUNCTION: Crucial regulator of intestinal secretion and bone
CC       growth (By similarity). Phosphorylates and activates CFTR on the
CC       plasma membrane. Plays a key role in intestinal secretion by
CC       regulating cGMP-dependent translocation of CFTR in jejunum (By
CC       similarity). Acts downstream of NMDAR to activate the plasma
CC       membrane accumulation of GRIA1/GLUR1 in synapse and increase
CC       synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By
CC       similarity). Acts as regulator of gene expression and activator of
CC       the extracellular signal-regulated kinases MAPK3/ERK1 and
CC       MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid
CC       shear stress, mediates ERK activation and subsequent induction of
CC       FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the
CC       osteoblast anabolic response to mechanical stimulation (By
CC       similarity). {ECO:0000250|UniProtKB:Q61410,
CC       ECO:0000250|UniProtKB:Q64595}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Binding of cGMP results in enzyme activation.
CC       {ECO:0000269|PubMed:26769964}.
CC   -!- SUBUNIT: Interacts with GRIA1/GLUR1.
CC       {ECO:0000250|UniProtKB:Q64595}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:8636133}; Lipid-anchor
CC       {ECO:0000269|PubMed:8636133}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13237-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13237-2; Sequence=VSP_055121;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly concentrated in brain, lung and
CC       intestinal mucosa.
CC   -!- PTM: Myristoylation mediates membrane localization.
CC       {ECO:0000269|PubMed:8636133}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cGMP subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X94612; CAA64318.1; -; mRNA.
DR   EMBL; D70899; BAA18934.1; -; mRNA.
DR   EMBL; AK297673; BAG60035.1; -; mRNA.
DR   EMBL; AC098819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139722; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Y16106; CAA76073.1; -; Genomic_DNA.
DR   EMBL; Y16107; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16108; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16109; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16110; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16111; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16112; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16113; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16114; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16115; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16116; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16117; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16118; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16119; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16120; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16121; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16122; CAA76073.1; JOINED; Genomic_DNA.
DR   EMBL; Y16123; CAA76073.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS3589.1; -. [Q13237-1]
DR   CCDS; CCDS64005.1; -. [Q13237-2]
DR   PIR; S68217; S68217.
DR   RefSeq; NP_001269409.1; NM_001282480.1.
DR   RefSeq; NP_001269410.1; NM_001282481.1.
DR   RefSeq; NP_001269411.1; NM_001282482.1.
DR   RefSeq; NP_001269412.1; NM_001282483.1.
DR   RefSeq; NP_001269414.1; NM_001282485.1. [Q13237-2]
DR   RefSeq; NP_006250.1; NM_006259.2. [Q13237-1]
DR   RefSeq; XP_005263183.1; XM_005263126.3. [Q13237-1]
DR   UniGene; Hs.232044; -.
DR   UniGene; Hs.570833; -.
DR   UniGene; Hs.739943; -.
DR   PDB; 5BV6; X-ray; 1.94 A; A=269-418.
DR   PDB; 5C6C; X-ray; 2.05 A; A/B=137-277.
DR   PDB; 5C8W; X-ray; 1.80 A; A/B/C/D/E/F=137-277.
DR   PDBsum; 5BV6; -.
DR   PDBsum; 5C6C; -.
DR   PDBsum; 5C8W; -.
DR   ProteinModelPortal; Q13237; -.
DR   SMR; Q13237; -.
DR   BioGrid; 111579; 7.
DR   IntAct; Q13237; 3.
DR   STRING; 9606.ENSP00000264399; -.
DR   BindingDB; Q13237; -.
DR   ChEMBL; CHEMBL2896; -.
DR   GuidetoPHARMACOLOGY; 1493; -.
DR   iPTMnet; Q13237; -.
DR   PhosphoSitePlus; Q13237; -.
DR   DMDM; 6226833; -.
DR   PaxDb; Q13237; -.
DR   PeptideAtlas; Q13237; -.
DR   PRIDE; Q13237; -.
DR   DNASU; 5593; -.
DR   Ensembl; ENST00000264399; ENSP00000264399; ENSG00000138669. [Q13237-1]
DR   Ensembl; ENST00000395578; ENSP00000378945; ENSG00000138669. [Q13237-1]
DR   Ensembl; ENST00000628926; ENSP00000486129; ENSG00000138669. [Q13237-2]
DR   GeneID; 5593; -.
DR   KEGG; hsa:5593; -.
DR   UCSC; uc003hmh.3; human. [Q13237-1]
DR   CTD; 5593; -.
DR   DisGeNET; 5593; -.
DR   GeneCards; PRKG2; -.
DR   HGNC; HGNC:9416; PRKG2.
DR   HPA; CAB018739; -.
DR   HPA; HPA007386; -.
DR   MIM; 601591; gene.
DR   neXtProt; NX_Q13237; -.
DR   OpenTargets; ENSG00000138669; -.
DR   PharmGKB; PA33778; -.
DR   eggNOG; KOG0616; Eukaryota.
DR   eggNOG; ENOG410XPQQ; LUCA.
DR   GeneTree; ENSGT00810000125385; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG006211; -.
DR   InParanoid; Q13237; -.
DR   KO; K19477; -.
DR   OMA; ELQSKCI; -.
DR   OrthoDB; EOG091G0S9R; -.
DR   PhylomeDB; Q13237; -.
DR   TreeFam; TF313261; -.
DR   BRENDA; 2.7.11.12; 2681.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-418457; cGMP effects.
DR   SignaLink; Q13237; -.
DR   SIGNOR; Q13237; -.
DR   GenomeRNAi; 5593; -.
DR   PRO; PR:Q13237; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138669; -.
DR   CleanEx; HS_PRKG2; -.
DR   ExpressionAtlas; Q13237; baseline and differential.
DR   Genevisible; Q13237; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004692; F:cGMP-dependent protein kinase activity; TAS:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:2001226; P:negative regulation of chloride transport; IEA:Ensembl.
DR   GO; GO:0036289; P:peptidyl-serine autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:CAFA.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; IEA:Ensembl.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR002374; cGMP_dep_kinase.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00027; cNMP_binding; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000559; cGMP-dep_kinase; 1.
DR   PRINTS; PR00104; CGMPKINASE.
DR   SMART; SM00100; cNMP; 2.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF51206; SSF51206; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 2.
DR   PROSITE; PS00889; CNMP_BINDING_2; 2.
DR   PROSITE; PS50042; CNMP_BINDING_3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane; cGMP;
KW   cGMP-binding; Coiled coil; Complete proteome; Kinase; Lipoprotein;
KW   Membrane; Myristate; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:8636133}.
FT   CHAIN         2    762       cGMP-dependent protein kinase 2.
FT                                /FTId=PRO_0000086123.
FT   DOMAIN      453    711       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      712    762       AGC-kinase C-terminal.
FT   NP_BIND     232    235       cAMP or cGMP 1. {ECO:0000244|PDB:5C6C,
FT                                ECO:0000244|PDB:5C8W,
FT                                ECO:0000269|PubMed:26769964}.
FT   NP_BIND     242    243       cAMP or cGMP 1. {ECO:0000244|PDB:5C6C,
FT                                ECO:0000244|PDB:5C8W,
FT                                ECO:0000269|PubMed:26769964}.
FT   NP_BIND     357    359       cAMP or cGMP 2. {ECO:0000244|PDB:5BV6,
FT                                ECO:0000269|PubMed:26769964}.
FT   NP_BIND     366    367       cAMP or cGMP 2. {ECO:0000244|PDB:5BV6,
FT                                ECO:0000269|PubMed:26769964}.
FT   NP_BIND     459    467       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      168    283       cGMP-binding, high affinity; cAMP-
FT                                binding, moderate affinity.
FT                                {ECO:0000305|PubMed:26769964}.
FT   REGION      286    416       cGMP-binding, high affinity; cAMP-
FT                                binding, low affinity.
FT                                {ECO:0000305|PubMed:26769964}.
FT   COILED       23     85       {ECO:0000255}.
FT   ACT_SITE    576    576       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     347    347       cAMP or cGMP 2.
FT                                {ECO:0000269|PubMed:26769964,
FT                                ECO:0000312|PDB:5BV6}.
FT   BINDING     412    412       cAMP or cGMP 2.
FT                                {ECO:0000269|PubMed:26769964,
FT                                ECO:0000312|PDB:5BV6}.
FT   BINDING     415    415       cAMP or cGMP 2.
FT                                {ECO:0000269|PubMed:26769964,
FT                                ECO:0000312|PDB:5BV6}.
FT   BINDING     482    482       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     110    110       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64595}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64595}.
FT   MOD_RES     431    431       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64595}.
FT   MOD_RES     609    609       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q61410}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:8636133}.
FT   VAR_SEQ     441    469       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055121.
FT   VARIANT      22     22       T -> S (in dbSNP:rs34956759).
FT                                /FTId=VAR_051633.
FT   VARIANT     106    106       H -> R (in dbSNP:rs34616910).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040608.
FT   VARIANT     716    716       W -> R (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040609.
FT   MUTAGEN     412    412       D->A: Reduces cGMP binding affinity; when
FT                                associated with A-415.
FT                                {ECO:0000269|PubMed:26769964}.
FT   MUTAGEN     415    415       R->A: Reduces cGMP binding affinity; when
FT                                associated with A-412.
FT                                {ECO:0000269|PubMed:26769964}.
FT   CONFLICT     57     58       QL -> HG (in Ref. 2; BAA18934).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       S -> I (in Ref. 5; CAA76073).
FT                                {ECO:0000305}.
FT   CONFLICT    388    388       N -> D (in Ref. 3; BAG60035).
FT                                {ECO:0000305}.
FT   CONFLICT    460    460       G -> A (in Ref. 2; BAA18934).
FT                                {ECO:0000305}.
FT   HELIX       153    164       {ECO:0000244|PDB:5C8W}.
FT   HELIX       169    171       {ECO:0000244|PDB:5C8W}.
FT   HELIX       174    183       {ECO:0000244|PDB:5C8W}.
FT   STRAND      185    189       {ECO:0000244|PDB:5C8W}.
FT   STRAND      194    196       {ECO:0000244|PDB:5C8W}.
FT   STRAND      204    211       {ECO:0000244|PDB:5C8W}.
FT   STRAND      213    217       {ECO:0000244|PDB:5C8W}.
FT   STRAND      220    224       {ECO:0000244|PDB:5C8W}.
FT   STRAND      230    232       {ECO:0000244|PDB:5C8W}.
FT   HELIX       233    238       {ECO:0000244|PDB:5C8W}.
FT   STRAND      243    250       {ECO:0000244|PDB:5C8W}.
FT   STRAND      252    258       {ECO:0000244|PDB:5C8W}.
FT   HELIX       259    266       {ECO:0000244|PDB:5C8W}.
FT   HELIX       270    283       {ECO:0000244|PDB:5BV6}.
FT   HELIX       285    287       {ECO:0000244|PDB:5BV6}.
FT   HELIX       292    301       {ECO:0000244|PDB:5BV6}.
FT   STRAND      303    307       {ECO:0000244|PDB:5BV6}.
FT   STRAND      312    314       {ECO:0000244|PDB:5BV6}.
FT   STRAND      323    335       {ECO:0000244|PDB:5BV6}.
FT   STRAND      344    350       {ECO:0000244|PDB:5BV6}.
FT   HELIX       357    362       {ECO:0000244|PDB:5BV6}.
FT   STRAND      368    372       {ECO:0000244|PDB:5BV6}.
FT   STRAND      377    382       {ECO:0000244|PDB:5BV6}.
FT   HELIX       384    389       {ECO:0000244|PDB:5BV6}.
FT   TURN        390    393       {ECO:0000244|PDB:5BV6}.
FT   HELIX       395    415       {ECO:0000244|PDB:5BV6}.
SQ   SEQUENCE   762 AA;  87432 MW;  FA7BA149906B5996 CRC64;
     MGNGSVKPKH SKHPDGHSGN LTTDALRNKV TELERELRRK DAEIQEREYH LKELREQLSK
     QTVAIAELTE ELQNKCIQLN KLQDVVHMQG GSPLQASPDK VPLEVHRKTS GLVSLHSRRG
     AKAGVSAEPT TRTYDLNKPP EFSFEKARVR KDSSEKKLIT DALNKNQFLK RLDPQQIKDM
     VECMYGRNYQ QGSYIIKQGE PGNHIFVLAE GRLEVFQGEK LLSSIPMWTT FGELAILYNC
     TRTASVKAIT NVKTWALDRE VFQNIMRRTA QARDEQYRNF LRSVSLLKNL PEDKLTKIID
     CLEVEYYDKG DYIIREGEEG STFFILAKGK VKVTQSTEGH DQPQLIKTLQ KGEYFGEKAL
     ISDDVRSANI IAEENDVACL VIDRETFNQT VGTFEELQKY LEGYVANLNR DDEKRHAKRS
     MSNWKLSKAL SLEMIQLKEK VARFSSSSPF QNLEIIATLG VGGFGRVELV KVKNENVAFA
     MKCIRKKHIV DTKQQEHVYS EKRILEELCS PFIVKLYRTF KDNKYVYMLL EACLGGELWS
     ILRDRGSFDE PTSKFCVACV TEAFDYLHRL GIIYRDLKPE NLILDAEGYL KLVDFGFAKK
     IGSGQKTWTF CGTPEYVAPE VILNKGHDFS VDFWSLGILV YELLTGNPPF SGVDQMMTYN
     LILKGIEKMD FPRKITRRPE DLIRRLCRQN PTERLGNLKN GINDIKKHRW LNGFNWEGLK
     ARSLPSPLQR ELKGPIDHSY FDKYPPEKGM PPDELSGWDK DF
//
